GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a substantial development in how we treat diabetes mellitus . These new medications work by imitating the body’s inherent GLP-1 process, https://followbookmarks.com/story21857452/glp-1-a-significant-approach-in-diabetes-management